Navigation Links
Barr Confirms Patent Challenge of Prevacid(R) SoluTab(TM) Delayed-Release Orally Disintegrating Tablets, 15mg and 30mg
Date:6/10/2008

MONTVALE, N.J., June 10 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NYSE: BRL) today confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patents listed by TAP Pharmaceuticals Inc. in connection with its Prevacid(R) SoluTab(TM) Delayed-Release Orally Disintegrating Tablets (lansoprazole), 15mg and 30mg.

Barr filed its Abbreviated New Drug Application (ANDA) containing a paragraph IV certification for a generic Prevacid SoluTab product with the U.S. Food & Drug Administration (FDA) in November 2007. Following receipt of the notice from the FDA that Barr's ANDA had been accepted for filing, Barr notified the New Drug Application (NDA) and patent holder.

On June 9, 2008, Ethypharm, S.A., Takeda Pharmaceutical Co., Ltd. and TAP Pharmaceuticals Inc. filed suits in the U.S. District Court for the District of Delaware to prevent Barr from proceeding with the commercialization of its product. This action formally initiates the patent challenge process under the Hatch-Waxman Act.

Prevacid SoluTab (lansoprazole) had annual sales of approximately $428 million in the U.S., based on IMS sales data for the 12-month period ending March 2008.

About Barr Pharmaceuticals, Inc.

Barr Pharmaceuticals, Inc. is a global specialty pharmaceutical company that operates in more than 30 countries worldwide and is engaged in the development, manufacture and marketing of generic and proprietary pharmaceuticals, biopharmaceuticals and active pharmaceutical ingredients. A holding company, Barr operates through its principal subsidiaries: Barr Laboratories, Inc., Duramed Pharmaceuticals, Inc. and PLIVA d.d. and its subsidiaries. The Barr Group of companies markets more than 120 generic and 27
'/>"/>

SOURCE Barr Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Clarification on Press Release Issued Earlier Today: Targeted Genetics Confirms Positive, Interim Phase 1/2 Study Findings
2. Barr Confirms Patent Challenge of Entocort(R), 3mg Enteric Coated Capsules
3. Kiwa Bio-Tech Confirms Joint Venture Agreement With Shijiazhuang Huaxing Animal Medicine Co., Ltd.
4. Two Year Study Confirms SUPPRELIN(R) LA Implant Maintains Profound Suppression of Hormones in Children With Premature Onset Puberty
5. Study Confirms Anti-Infective ARIKACE(TM) Effectively Penetrates Mucus and Biofilm, and Kills Pseudomonas, a Bacteria Plaguing Cystic Fibrosis Patients
6. U.S. Patent Office Confirms Validity of Osteotechs U.S. Patent No. 5,676,146
7. Research Confirms Better Oil from New DuPont High Oleic Soybean Trait
8. Publication in Clinical Cancer Research Confirms Ability of Peregrines Bavituximab to Target Tumor Blood Vessels with Excellent Specificity
9. PPD Confirms Takedas NDA Filing of Alogliptin with U.S. Food and Drug Administration
10. Barr Confirms Patent Challenge of Avodart(R) Soft Gelatin Capsules, 0.5mg
11. Icahn Confirms Intention to Nominate Three Directors at Biogen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2010)... months ahead of schedule ,, TSX Exchange Symbol: RVX ... Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today the ... study of its lead drug RVX-208. "The completion of ... 5 months ahead of our original schedule, is a ... at the Cleveland Clinic. At this rate we could ...
(Date:2/8/2010)... clinical services team to present the critical processes that comprise ... departments. , ... Chicago, IL (PRWEB) ... Trial Operations (CTO) software, today announced that both Kristin Lucas ... selected to speak at the CBI Forecasting & Budgeting conference ...
(Date:2/8/2010)... SAN DIEGO , Feb. 8 ... that it has appointed William H. Rastetter Ph.D. to ... current Chairman and Chief Executive Officer of Receptos, Inc., ... "We are very pleased to welcome Bill Rastetter ... A. Mollica , Ph.D., Chairman of the Board of ...
(Date:2/8/2010)... is pleased to announce that it has hired Lisa Wichman and Sahar ... joins HDS as an Account Manager and will focus on key healthcare ... the Manager of that group Omaha, NE. , ... Foothill Ranch, CA ... pleased to announce the hiring of a new Account Manager and Manager ...
Breaking Biology Technology:Resverlogix Completes Patient Recruitment for ASSERT Trial 2Resverlogix Completes Patient Recruitment for ASSERT Trial 3Resverlogix Completes Patient Recruitment for ASSERT Trial 4ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 2ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 3ClearTrial Selected to Provide Methodologies for Accurately Forecasting and Budgeting Clinical Spend and Integrated Financial Controls at CBI Conference 4Neurocrine Biosciences Announces the Appointment of William H. Rastetter to Its Board of Directors 2Healthcare Data Solutions Announces Expansion of its Healthcare Customer Solutions Team With Two Key Additions 2Healthcare Data Solutions Announces Expansion of its Healthcare Customer Solutions Team With Two Key Additions 3
... 4 Imaging Diagnostic,Systems, Inc., (OTC Bulletin Board: IMDS), ... a new study evaluating the CTLM system as an,adjunct ... of Academic,Radiology. , ... Alexander Poellinger, MD, a radiologist at Charite Hospital in ...
... HARLEYSVILLE, Pa., Dec. 4 Raymond J. De Hont, Chairman and ... today that the Company,s Board of Directors, at their meeting on ... payable on March 12, 2009 to shareholders of record at the ... a 9.1% increase over the same period last year. , ...
... Pharma Limited ("Azur") today,announced that it has entered ... BPAX ) to acquire U.S. rights ... of estradiol which is,indicated for the treatment of ... was approved by the U.S. Food and Drug,Administration ...
Other Biology Technology:Imaging Diagnostic Systems CT Laser Mammography (CTLM) Technology Featured in Peer-Reviewed Journal 2Met-Pro Corporation Declares Quarterly Dividend 2Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM) 2
(Date:2/7/2010)... health habits or behaviors, like cigarette smoking, may influence ... against HPV. , According to survey results on ... to vaccinate their daughters was not associated with one,s ... with certain behavioral factors of the parents. , Results ... of Cancer Epidemiology, Biomarkers & Prevention , a ...
(Date:2/7/2010)... per week increased the risk of developing pancreatic cancer ... consume soft drinks, according to a report in ... the American Association for Cancer Research. , Although ... deadly, and only 5 percent of people who are ... Ph.D., senior author on the study and associate professor ...
(Date:2/7/2010)... PAUL, Minn. Workers exposed to tricholorethylene (TCE), a ... auto parts, may be at a significantly higher risk ... today that will be presented at the American Academy ... to April 17, 2010. , "This is the first ... exposure to TCE may increase a person,s risk of ...
Breaking Biology News(10 mins):More smokers than non-smokers accept HPV vaccination for their daughters 2More smokers than non-smokers accept HPV vaccination for their daughters 3Soft drink consumption may increase risk of pancreatic cancer 2Elephant size loopholes sustain Thai ivory trade 8912 1Elephant size loopholes sustain Thai ivory trade 8912 2Hospira Receives Favorable Court Decision on Eloxatin 28R 29 12701 1Hospira Receives Favorable Court Decision on Eloxatin 28R 29 12701 2Hospira Receives Favorable Court Decision on Eloxatin 28R 29 12701 3K State Veterinarian Says Although Exotic Pets Can Be Great Companions There Are Health Factors That Can Affect Both the Animal and Humans 49435 1K State Veterinarian Says Although Exotic Pets Can Be Great Companions There Are Health Factors That Can Affect Both the Animal and Humans 49435 2K State Veterinarian Says Although Exotic Pets Can Be Great Companions There Are Health Factors That Can Affect Both the Animal and Humans 49435 3
... MADISON, WI, OCTOBER 20, 2008 -- The widespread use of ... decades, with little knowledge of the long-term effects on the ... study show that samples taken from over 300 wells across ... contamination. The news is a result of a decadal long ...
... Fritz et al. have identified an amino acid switch ... such as tick-borne encephalitis virus (TBEV), yellow fever, and ... cells by being gobbled up into endosomes and fusing ... triggered by the endosome,s acidic environment. Low pH prompts ...
... -- Researchers are one step closer to finding a ... for TB tested at Saint Louis University appears likely ... disease than the one in current use. , "Not ... it induced a better immune response, which suggests it ...
Other Biology News:Pesticide concentrations decreasing 2Research identifies type of vaccine that holds promise in protecting against TB 2
... (Dual-Stage Quadrupole) Thermo Scientific (Part of Thermo ... instrumentation, introduces the latest product innovation for ... on the proven reliability and performance platform ... the DSQ II incorporates the new DynaMax ...
... Library Panels were designed for full-length gene ... PCRs to identify the desired cDNA clone. ... a 96-well "Master Plate," where each well ... identified the positive well(s) by gel electrophoresis ...
... The ProteoSpin CBED Micro Kit provides a ... exchange and desalting of protein samples. The ... Norgens patented protein resin as an ion ... CaCl2,LiCl, CsCl have poor affinities for Norgens ...
... Pathway 435 is an affordable, compact ... and slides, providing a broad array ... rapidly acquires high-resolution images with high-performance ... computer-controlled excitation and emission filter changers, ...
Biology Products: